Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASAH1 | Q13510 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7906152 | 0.76 | FAAH (0.47) | CYP1A2MAPTCYP2C9CYP2C19TP53 | |
| SCHEMBL5206485 | 0.76 | MEN1 (0.47) | MAPK1ASAH2EP300MEN1KMT2A | |
| SCHEMBL1416049 | 0.75 | EP300 (0.42) | CYP1A2MAPTCYP2C9CYP2C19TP53 | |
| SCHEMBL1415757 | 0.74 | FAAH (0.47) | EP300FAAHCNR1CNR2 | |
| SCHEMBL5205427 | 0.73 | MMP1 (0.41) | MAPK1MEN1KMT2ATHRBFAAH | |
| SCHEMBL27721682 | 0.73 | ASAH2 (0.66) | ASAH2TP53MEN1KMT2ATHRB | |
| SCHEMBL9429318 | 0.71 | MAPT (0.50) | CYP1A2MAPTCYP2C9CYP2C19TP53 | |
| SCHEMBL10704983 | 0.70 | SLC6A5 (0.49) | CYP1A2CYP2C19TP53MEN1KMT2A | |
| SCHEMBL17707230 | 0.70 | TSHR (0.50) | CYP1A2MAPTCYP2C9CYP2C19TP53 | |
| SCHEMBL159834 | 0.70 | EP300 (0.56) | CYP1A2MAPTCYP2C9CYP2C19EP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064723-A1 | Aminocyclohexane carboxylic acid and its esters, aminocyclohexane derivatives such as aminocyclohexanol, and piperidinecarboxylic acid and its esters, hydroxypiperidine ; applied to human scalp | SHISEIDO COMPANY, LTD. (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1806121-A1 | ANTI-GRAYING PREPARATION | Shiseido Company, Limited (JP) | 2007-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064723-A1 | Aminocyclohexane carboxylic acid and its esters, aminocyclohexane derivatives such as aminocyclohexanol, and piperidinecarboxylic acid and its esters, hydroxypiperidine ; applied to human scalp | HCAR1, HCAR3, DDC | ASAH1 161/4885CYP1A2 692/4885MAPT 3222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.